GE HealthCare (NASDAQ: GEHC), a leading medical technology firm, has entered into a cooperation intent letter with the Pudong district of Shanghai, committing an investment of RMB 380 million (USD 52.5 million). This strategic partnership will focus on the introduction of new products, construction of new production lines, green factory updates, smart manufacturing, and digital transformation initiatives.
As part of this collaboration, GE’s Shanghai base will be renamed to “GE HealthCare Diagnostic Medicine Belt and Road Initiative Smart Manufacturing Center of Excellence.” The new center aims to harness diagnostic medicines to benefit patients globally, with a focus on products manufactured in China.- Flcube.com
